文献速递肝胆胰外科围术期管理与 ERAS

胰腺导管腺癌胰十二指肠切除术的手术入路:无并发症时微创更具优势

Surgical approach to pancreaticoduodenectomy for pancreatic adenocarcinoma: uncomplicated ends justify the means.
PubMed 文献 · Surg Endosc · 2021-12-02

该研究利用2014-2019年NSQIP胰腺切除靶向数据库,按是否发生胰腺切除特异性并发症(PSM,定义为胃排空延迟和/或术后胰瘘)分组,倾向性评分匹配后比较微创与开放胰十二指肠切除术的短期结局。无PSM组中,微创手术总并发症更少、住院时间更短、出院回家率更高;发生PSM组中,微创手术无短期获益。

要点

  • 无PSM时,微创胰十二指肠切除术总并发症22.1% vs 开放29.1%,住院中位时间6 vs 7天。
  • 发生PSM时,微创与开放的总并发症、住院时间、死亡率和再入院率相似。
  • PSM在胰腺导管腺癌胰十二指肠切除术后常见。

核心结论

  • PSM在胰腺导管腺癌胰十二指肠切除术后常见。
  • 在无PSM时,微创胰十二指肠切除术与更少的术后并发症和更短的住院时间相关。

研究设计与样本

  • 利用NSQIP胰腺切除靶向数据库2014-2019年数据。
  • 共纳入8121例患者,分为无PSM组(N=6267)和PSM组(N=1854)。
  • PSM定义为发生胃排空延迟和/或术后胰瘘。
  • 在各组内应用倾向性评分匹配比较微创与开放胰十二指肠切除术的结局。

主要发现

  • 无PSM组匹配1656例开放与552例微创患者,微创手术时间更长(423 vs 359 min;p<0.001),但总并发症更少(22.1% vs 29.1%;p=0.001),主要归因于出血和脓毒症更少。
  • 无PSM组微创患者中位住院时间缩短一天(6 vs 7天;p=0.005),出院回家率更高(92.8% vs 89.6%;p=0.027),死亡率和30天再入院无差异。
  • PSM组匹配441例开放与147例微创患者,微创手术时间更长但无短期获益;总并发症(61.2% vs 61.9%)、中位住院时间(12 vs 12天)、死亡率(2.7% vs 1.8%)和再入院率(32.7% vs 26.5%)相似。
  • 符合方案分析得出相同结论。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pancreaticoduodenectomy (PD) remains the cornerstone of managing pancreatic ductal adenocarcinoma (PDAC) of the pancreas head/neck, but it is associated with high morbidity. We hypothesize that, in absence of pancreatectomy-specific morbidity (PSM), minimally invasive PD (MIPD) provides improved short-term outcomes compared to open PD (OPD). METHODS: NSQIP pancreatectomy-targeted database 2014-2019 was utilized. PSM was defined as the occurrence of delayed gastric emptying (DGE) and/or post-operative pancreatic fistula (POPF). The cohort was divided into No-PSM and PSM groups. Propensity score match was applied in each group to compare outcomes of MIPD vs. OPD. RESULTS: 8,121 patients were selected. Patients were divided into No-PSM (N = 6267) and PSM (N = 1854) groups. In No-PSM group, we matched 1656 OPD to 552 MIPD patients. MIPD had longer operations (423 vs. 359 min; p < 0.001) but less overall morbidity (22.1% vs. 29.1%; p = 0.001) mostly attributed to less bleeding and sepsis. MIPD patients also had a one-day shorter median LOS (6 vs. 7 days; p = 0.005) and higher rates of home discharge (92.8% vs. 89.6%; p = 0.027). No difference was noted in mortality and 30-day readmission. In PSM group, 441 OPD were matched to 147 MIPD peers. MIPD had longer operations but without short-term benefits. General morbidity (61.2% vs. 61.9%), median LOS (12 vs. 12 days), mortality (2.7% vs. 1.8%), and readmission rates (32.7% vs. 26.5%) were similar. Same conclusions were drawn in the per-protocol analysis. CONCLUSION: PSM is common following PD for PDAC. In the absence of PSM, MIPD is associated with less postoperative morbidity and shorter LOS.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Naffouje SA, Pointer DT, Satyadi MA, et al. Surgical approach to pancreaticoduodenectomy for pancreatic adenocarcinoma: uncomplicated ends justify the means. Surg Endosc. 2021. PMID: 34859301. doi:10.1007/s00464-021-08845-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。